| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1c88da57ed94819c156a0fad624caa1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32334 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd3d7396c01203f10ededb513c387ca4 |
| publicationDate |
2019-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019008599-A1 |
| titleOfInvention |
VACCINE COMPOSITION BASED ON SYNTHETIC POLYPEPTIDE EPITOPE |
| abstract |
The invention relates to conserved epitopes selected from EV71 and CVA16, the two main agents responsible for FMD have been used to develop a subunit divalent vaccine antigen structure. The vaccine described in the present invention is capable of providing cross-protection against various infectious strains of EV71 and CVA16. The invention further relates to the expression of the gene encoding the multi-epitope vaccine antigen and its purification method. The present invention also relates to vaccine formulations against foot-and-mouth disease and other enterovirus infections comprising the recombinant vaccine antigen structure of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109966482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2604692-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111171117-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111171117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022070210-A1 |
| priorityDate |
2017-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |